September 2012 pulmonary journal club

No abstract available. Article truncated at 150 words. Dr. Mathew was away this month and we reviewed 4 articles.Kelly HW, Sternberg AL, Lescher R, Fuhlbrigge AL, Williams P, Zeiger RS, Raissy HH, Van Natta ML, Tonascia J, Strunk RC; CAMP Research Group.Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 2012;367:904-12. The use of inhaled glucocorticoids for persistent asthma causes a temporary reduction in growth velocity in prepubertal children but it is unclear whether the child is permanently shortened or attains a normal adult height. Starting at the age of 5 to 13 years, the participants had been randomly assigned to receive 400 μg of budesonide, 16 mg of nedocromil, or placebo daily for 4 to 6 years. The authors measured adult height in 943 of 1041 participants (90.6%). Mean adult height was 1.2 cm lower the budesonide group than in the placebo group (P = 0.001) A larger daily dose of